http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010047803-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb96efc2b98c79c02138d90cb3ad3ca5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f76c1f9434a03c898a68cdffa6754c5d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 2009-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8908bf34e17faa86880392f3c469c073
publicationDate 2010-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010047803-A3
titleOfInvention A method for the treatment of proliferative disorders of the eye
abstract The present invention relates to method for the treatment or prevention and of proliferative eye diseases including but not limited to: age related macular degeneration associated proliferative retinopathy, proliferative diabetic retinopathy, proliferative vitreoretinopathy, posterior capsular opacification, scaring and fibrosis after glaucoma filtration surgery, uveal melanoma, and retinoblastoma. The method comprises contacting cells in the eye by means of intra-ocular injection or infusion, with a drug that irreversibly inhibits cellular proliferation without causing extensive tissue necrosis or cytotoxicity. In a preferred embodiment the drug is bizelesin.
priorityDate 2008-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002165522-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003060763-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006154893-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005092844-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006079472-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415729306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60794

Total number of triples: 25.